- 5 major GI groups to know
- MB2 Dental adds 5 new partners in 2 months
- Penn Medicine expects $105M ROI from AI
- Arizona spine practice opens ASC
- Oklahoma CRNA charged with misconduct
- 8 health systems, more than $1.4B in capital projects in May
- RFK Jr. visits Summa Health
- Kaiser Permanente plans 11K-square-foot MOB in Nevada
- Dentistry’s AI gold rush
- Community Health Network taps new CFO from Aspirus Health
- California creates $25M fund for at-risk hospitals
- Only 1 in 5 physicians is independent: 10 new numbers behind the collapse
- California physician group acquired by PRISM
- Behavioral health ED visits projected to rise by 1 million
- When your AI agent goes off script: What Moffitt Cancer Center caught early
- Utah physician, 2 nurses charged in $29M fraud scheme
- 3 Ascension CFO moves in 2 days
- The volume paradox costing ASCs millions
- Pediatric radiology leaders launch AI brain tumor dataset
- Inside SCA Health’s clinical nursing ladder — and how it helped cut turnover by 7%
- What ASCs are getting wrong about OR delays — and how to fix it
- 1 behavioral health leader’s playbook for staff retention and safety
- Centene executive to join Froedtert ThedaCare as chief nurse
- Behavioral health ED visits projected to rise by 1 million
- 5 dental AI updates in 1 month
- 3 lawsuit settlements in dentistry
- Financial pressures shutter Iowa dental clinics: 4 notes
- Independent autism research committee adds 7 members
- FDA Commissioner Marty Makary Resigns After Trump Pressure
- 10 notes on the widening DSO performance gap
- CDC-linked autism researcher arraigned on fraud charges
- Nearly 1 in 3 boys under 14 discussed suicide in crisis conversations: Report
- As Trump arrives in China, Big Pharma CEOs are notably absent
- Remarks at the MFA Legal & Compliance 2026 Conference
- CMS pauses hospice, home health Medicare enrollments in fraud crackdown
- GLP-1 Drugs May Improve Breast Cancer Outcomes
- NYU Langone Health says it received grand jury subpoena over gender-affirming care
- Merck KGaA looks to M&A to bolster its 'rather slim' pipeline
- Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
- BeOne Medicines’ Brukinsa TV ad 'Clarity' hit by FDA over 'misleading suggestions'
- Health systems are exploring AI-powered cardiac risk screening. New CMS reimbursement could unlock a business case for it
- Ted Turner's Brain Disease More Common Than Previously Thought, Review Finds
- Most mental health practitioners satisfied with work, financially stable, SimplePractice finds
- Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies
- Haleon tackles sports injuries with latest soccer play
- Perimenopausal Women Face Greater Heart Risk, Study Finds
- Ivermectin Prescriptions Doubled After Mel Gibson Cancer Cure Claim
- Eating Out Linked To Obesity Risk Worldwide
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- RFK Jr. Swaps Vaccine Talk for Healthy Foods and Reading to Tots in Push To Woo Voters
- Trump and Kennedy Seek To Relax Safeguards for AI Healthcare Tools
- Valneva to lay off up to 15% of workforce in face of ‘adverse trend’ in travel vaccines
- California to award $111M for behavioral health supportive housing
- 6 new psychiatric residency programs to know
- USOSM adds New York practice
- NAMI partners on health crisis preparation hub
- Oklahoma enacts law expanding access to dental care
- Where dentists are leaving value behind in practice sales
- Why dental practices are closing in 2026
- Mayo Clinic CEO Gianrico Farrugia stepping down at year's end
- 988 calls are rising — what’s behind the surge?
- Providence hospital to lay off 40 workers amid behavioral health staffing overhaul
- BioMarin consolidates staff at Amicus HQ after closing $4.8B deal for rare disease peer
- US Monitors For Hantavirus As WHO Expects More Cases But 'Not Another COVID'
- University of California, union near May 14 strike deadline with no deal in hand
- 1 in 5 marketplace enrollees dropped their coverage in 2026: media report
- Hims & Hers posts $92M loss in Q1 as it shifts to branded GLP-1 medications
- Listen to the Latest ‘KFF Health News Minute’
- FDA Commissioner Marty Makary to resign, capping turbulent tenure
- FDA Commissioner Marty Makary to resign, capping turbulent tenure
- Providence puts years of losses in rearview with its third consecutive quarter of operating gains
- Millions of Women Suffer in Silence From Treatable Pelvic Organ Prolapse
- Eli Lilly pauses Indian obesity awareness campaign after regulatory notices: report
- Optum Rx unveils new transparent PBM model
- Fitness wearable Whoop adds on-demand clinician access, EHR syncing
- Alkermes’ Lumryz hits phase 3 mark in another sleep disorder, fueling momentum from $2.4B Avadel acquisition
- ACA exchanges take spotlight in Q1
- Bayer's Eylea declines by 24%, bearing the brunt of biosmilar competition
- Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu
- As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT
- As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT
- What's Fueling The High U.S. Death Rate? It Might Not Be What You Think
- Telemedicine Not Breaking The Bank, Also Not Expanding Patient Access
- After-School Sports An Overall Boon To Children And Teens, Study Shows
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up
- Why Are Older Adults Taking Edibles? Survey Reveals Some Surprises
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- EU advances scheme to bolster manufacturing autonomy, avert drug shortages
- Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer
- The broken pipeline of mental healthcare for LGBTQ teenagers
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- Is your hospital ready for a prolonged IT outage? Joint Commission, AHA's new resiliency program will let you know
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- Roche acquires PathAI to transform AI-driven diagnostics
- Roche acquires PathAI to transform AI-driven diagnostics
- Trump Planning to Fire FDA Commissioner Marty Makary
- Trump Planning to Fire FDA Commissioner Marty Makary
- Included Health launches AI-powered solution to connect members to providers
- FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer
- The Hidden Design Flaw in Medical Device Service Technology
- The Hidden Design Flaw in Medical Device Service Technology
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- 8,500 Steps A Day Could Be Sweet Spot For Preventing Weight Regain
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Survey: Employers seeking greater transparency from pharmacy benefits
- Kaiser Permanente's investments pick up the slack as Q1 operating margin slims to 2.1%
- AMA unveils policy framework to combat AI deepfake physician impersonation
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- CSL slashes revenue projection and takes $5B impairment as interim CEO flags R&D misses, market erosion
- Healthcare bankruptcies up 33% in Q1 2026: report
- Why Doctors Are Quitting At An Earlier Age
- Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
- Older Adults Have Fewer Regrets, Study Says
- Partner's bispecific Bizengri nabs FDA national priority nod in rare bile duct cancer
- Daiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan
- That Discount At The Pharmacy Counter May Pack Hidden Costs
- Nighttime Heat Waves Increase Asthma Risk
- As Ranks of Uninsured Grow, Minnesota’s Hospitals Are Among Least Charitable in Nation
- Watch: 8 Health Insurance Terms You Should Know
- OVID Health hires Edelman alum Davide Scalenghe to boost its international footprint
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Eli Lilly shoots for health in new Caitlin Clark ad campaign
- Omada Health posts 42% revenue jump in Q1, joins Eli Lilly employer weight loss program
- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- The Make America Healthy Again Movement Comes for Hospital Food
- Remarks at the Conference on Financial Market Regulation
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Skil-Care launches specialized healthcare product innovation program
- Remarks at the Special Competitive Studies Project AI+ Expo
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- Integrated CDO capabilities reduce early development complexity
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Workplace safety is a top priority for 93% of healthcare leaders: Axon survey
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- Remarks at the 13th Annual Conference on Financial Market Regulation
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
The Doctor Patient Forum is requesting public support for FDA regulation of NarxCare by May 10, 2025. They explain and link the FDA comment page in their YouTube video (2 min):
Flagged. Medically Abandoned. Forgotten. Unveiling NarxCare: The Hidden Scoring System in Your EHR.
Unfortunately, DPF's assumption of big government to the rescue fails the logic test. Federal regulation to solve state overreach is a non-starter, but there is a better way.
The State of Michigan directly added the Michigan Automated Prescription System (MAPS) into the electronic health records (EHRs) and pharmacy management systems of hospitals, physician groups and pharmacies across the state in 2017, according to owner Appriss press release and State of Michigan sources. Lt. Gov. Brian Calley signed the enabling bill into law.
That MAPS package included NarxCare.
It is administered by LARA, but don't forget - it began with state legislators, and can only end the same way.
Both parties in Lansing have been operating on the progressive philosophy that "When the government knows and controls, we have better health." Nothing could be further from the truth, as we ought to have learned from COVID.
However, the Doctor Patient Forum's strength is understanding patient impact of status quo Michigan law, and public awareness is the best way to correct law.
I highly recommend their insights into state prescription drug tracing and patient pain control.
https://www.painnewsnetwork.org/stories/2018/5/19/what-every-patient-should-know-about-narxcare
What Every Patient Should Know About NarxCare
May 19, 2018
Walmart and Sam’s Club recently announced that by the end of August their pharmacists will start using NarxCare, a prescription tracking tool that analyzes real-time data about opioids and other controlled substances from Prescription Drug Monitoring Programs (PDMP’s).
Recent studies question the value of PDMP’s, but 49 states have implemented them so that physicians, pharmacists and insurers can see a patient's medication history. Granted, there is a need for monitoring the select few who doctor shop and/or abuse their medications, albeit that number is only in the 2 percent range.
What is NarxCare? Appriss Health developed NarxCare as a “robust analytics tool” to help “care teams” (doctors, pharmacists, etc.) identify patients with substance use disorders. Each patient is evaluated and given a “risk score” based on their prescription drug history. According to Appriss, a patient is much more willing to discuss their substance abuse issues once they are red flagged as a possible abuser.
“NarxCare automatically analyzes PDMP data and a patient’s health history and provides patient risk scores and an interactive visualization of usage patterns to help identify potential risk factors,” the company says on its website.
“NarxCare aids care teams in clinical decision making, provides support to help prevent or manage substance use disorder, and empowers states with the comprehensive platform they need to take to the next step in the battle against prescription drug addiction."
Sounds great doesn't it? Except prescription drugs are not the problem and never really have been. Illicit drug use has, is, and will continue to be the main cause of the addiction and overdose crisis.
Even the name NarxCare has a negative connotation. “Narx” stands for narcotics. And in today's environment, narcotics is a very negative word. NarxCare makes me feel like a narcotics police officer is just around the corner.
Each patient evaluated by NarxCare gets a “Narx Report” that includes their NarxScores, Overdose Risk Score, Rx Graph, PDMP Data and my favorite, the Red Flags. The scores are based on the past two years of a patient’s prescription history, as well as their medical claims, electronic health records and even their criminal history.
Ohio, Michigan, Indiana, Iowa, and several other states are using NarxCare to supplement their own PDMPs. And Walmart isn’t the only big retail company to adopt it. Kroger, Ralphs, Kmart, CVS, Rite Aid and Walgreens are already using NarxCare. There’s a good chance your prescriptions are already being tracked by NarxCare and you don’t even know it.
But NarxCare doesn’t just analyze opioid prescriptions. It also tracks other controlled substances, such as antidepressants, sedatives and stimulants. If a patient is on any combination of those drugs, their risk scores and their chances of being red flagged will be higher – even if they’ve been safely taking the medications for years.
There are several other ways a patient can be red flagged, such as having multiple doctors or pharmacies. But what if you moved and changed physicians? What if you had the same physician for many years and he/she retired or moved away? What if your pharmacy refused to fill your prescription and you had to go pharmacy hunting every month? What if you had dental surgery and your dentist placed you on a short-term pain medication?
Unfortunately, the NarxCare scores do not reflect any of that. How can raw data on prescription medications be an indicator of abuse? I believe there is some merit in tracking and weeding out the rare abuser, but NarxCare doesn't factor in all the “what if’s” that can happen to law-abiding and responsible patients.
As pain patients, we need to be acutely aware of the negative impact this analytics tool can have. Many of us have already been required to sign pain contracts, take drugs tests, and undergo pill counts. In 2019, Medicare will adopt policies making it even harder for patients to get high doses of opioid medication. Some insurers are already doing it. We're already being policed enough as it is.
I intend to ask my physician, pharmacist and case manager if they utilize NarxCare. So should you. If they say yes, ask them why. Ask your doctor if they believe you are at risk for substance use disorder. Why is their judgement and treatment of you being second guessed by anyone?
Rochelle Odell lives in California. She’s lived for nearly 25 years with Complex Regional Pain Syndrome (CRPS/RSD).
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















